Angelus:
it's not a flame war to challenge facts.
sorry but the AFR is a pretty solid source and they make it clear that there is no failure on MSB's part to explain the lower SP. So it's not my personal opinion, it's fact.
Do you have any facts to explain why the SP is not a reflection of broader market sentiment on biotechs?
Either there is a factual basis for the drop or it's market sentiment. What else is there?
Manipulation you're ruling out?
Angelus:it's not a flame war to challenge facts. sorry but the...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |